You just read:

US Cancer Generics Market Outlook 2017-2022: Total Savings from Generics in Cancer Therapy (Treatment & Post Treatment) will Surpass US$ 30 Billion by 2022 - Research and Markets

News provided by

Research and Markets

Feb 27, 2017, 10:00 ET